Related Experiment Video
Updated: May 15, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expression
Pierre-François Cartron1, Christophe Blanquart, Eric Hervouet
1Centre de Recherche en Cancérologie Nantes-Angers, INSERM U892, Equipe Apoptose et Progression Tumorale, Equipe labellisée Ligue Nationale Contre le Cancer, 8 Quai Moncousu, BP 7021, 44007 Nantes, France. pierre-francois.cartron@univ-nantes.fr
Abstract:
The NY-ESO1 gene is a cancer/testis antigen considered to be suitable target for the immunotherapy of human malignancies. Despite the identification of the epigenetical silencing of the NY-ESO1 gene in a large variety of tumors, the molecular mechanism involved in this phenomenon is not fully elucidated. In two non epithelial cancers (glioma and mesothelioma), we found that the epigenetic regulation of the NY-ESO1 gene requires the sequential recruitment of the HDAC1-mSin3a-NCOR, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a complexes. Thus, our data illustrate the orchestration of a sequential epigenetic mechanism including the histone deacetylation and methylation, and the DNA methylation processes.
Insights
The NY-ESO1 gene, a cancer/testis antigen, is epigenetically silenced in tumors. This study reveals a sequential mechanism involving histone deacetylation, methylation, and DNA methylation in glioma and mesothelioma.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- The NY-ESO1 gene is a cancer/testis antigen and a potential target for cancer immunotherapy.
- Epigenetic silencing of the NY-ESO1 gene is observed in various tumors, but the underlying molecular mechanisms remain unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms of epigenetic regulation and silencing of the NY-ESO1 gene in non-epithelial cancers.
- To investigate the sequential recruitment of epigenetic modifiers involved in NY-ESO1 gene silencing.
Main Methods:
- Analysis of epigenetic regulation in glioma and mesothelioma cell lines.
- Identification of protein complexes involved in histone deacetylation, histone methylation, and DNA methylation.
Main Results:
- The epigenetic regulation of the NY-ESO1 gene involves the sequential recruitment of specific protein complexes.
- Key complexes identified include HDAC1-mSin3a-NCOR, Dnmt3b-HDAC1-Egr1, and Dnmt1-PCNA-UHRF1-G9a.
- This orchestration involves coordinated histone deacetylation, histone methylation, and DNA methylation processes.
Conclusions:
- The study demonstrates a sequential epigenetic mechanism responsible for NY-ESO1 gene silencing in glioma and mesothelioma.
- Understanding this mechanism provides insights into cancer/testis antigen regulation and potential therapeutic strategies for malignancies.
Related Concept Videos
Maintenance of the ES Cell State
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Master Transcription Regulators
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Cell Specific Gene Expression
Epigenetic Regulation
X-chromosome...

